Last reviewed · How we verify
NCT02806154: FRACTION
Frailty and Body Composition in the Elderly Cancer Patients Treated With Chemotherapy
trial testing DEXA in Cancer in 144 participants. Completed in 29 March 2023.
29 March 2023
Quick facts
| Lead sponsor | University Hospital, Toulouse |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 144 |
| Start date | 27 March 2017 |
| Primary completion | 29 March 2023 |
| Estimated completion | 29 March 2023 |
| Sites | 8 locations across France |
Drugs / interventions tested
- DEXA
Conditions studied
- Cancer — all drugs for Cancer →
Sponsor
University Hospital, Toulouse
Who can join
70 and older, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators could hypothesize that age-related changes in body composition parameters play a role in the variable tolerance to chemotherapy in the elderly.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Low lean mass and chemotherapy toxicity risk in the elderly: the Fraction study protocol.
Steinmeyer Z, Gérard S, Filleron T, Lozano S, et al · · 2019 · cited 6× · PMID 31775667 · DOI 10.1186/s12885-019-6377-7
Verify or expand the search:
- PubMed search for NCT02806154
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of DEXA
Trials testing the same drug.
- NCT06820658 — A Comparison of Neuromuscular Recruitment in Trained and Untrained Adults · recruiting
- NCT05313594 — Digital Twin - Modelling Postprandial Triglyceride and Glucose Responses · completed
- NCT04650659 — Functional Exercise Tests in Patients With Systemic Sclerosis · unknown
- NCT03663933 — Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation · Phase 2 · active not recruiting
- NCT03253055 — The D-BIICEP Study · completed
Other recruiting trials for Cancer
Currently open trials in the same condition.
- NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
- NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
- NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting
Other University Hospital, Toulouse trials
Trials by the same sponsor.
- NCT07497750 — Impact of Artificial Intelligence Algorithm-driven Versus Standard Lifestyle Intervention in Non-Alcoholic Fatty Liver D · NA · not yet recruiting
- NCT07507240 — The Benefits of a Care Pathway Combining Remote Monitoring and Support From a Nurse After a Change in Anti-epileptic Tre · NA · not yet recruiting
- NCT07524088 — Contamination of Young Children Hair During Acute Cannabis Intoxication · NA · not yet recruiting
- NCT07470580 — Radiofrequency Ablation Versus Adrenalectomy for Adenoma in Patients With Primary Aldosteronism and Hypertension · NA · not yet recruiting
- NCT07423988 — Evaluation of Changes in Sleep Efficiency Among PIC DU MIDI Staff Between Nights Spent at Home and Nights Spent in the W · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02806154 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Toulouse
- Last refreshed: 19 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02806154.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing